TITLE

Report on the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation

AUTHOR(S)
Fatuzzo, Giuseppe
PUB. DATE
June 2014
SOURCE
Ecancermedicalscience;2014, Vol. 8 Issue 413-446, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: The EBMT is a non-profit scientific society representing 563 transplant centres from 57 countries in and outside Europe. Background: From 29 March to 2 April 2014, the EBMT Annual Meeting took place at the Milan Convention Centre (MiCo), for the 40th Annual Meeting. Objective/Methods: This report will summarise the meeting's sessions and discuss the nursing scientific programme. Data source/extraction: programme, interview, presentations, and abstracts. Conclusions: This year's 40th Anniversary congress in Milan received a record number of abstract submissions plus an extremely high attendance of more than 4600 participants--the second highest in the history of the EBMT. The meeting provided a venue for a constructive multinational and multidisciplinary dialogue. EBMT continues to monitor differences between countries and spreads good clinical practice.
ACCESSION #
97255406

 

Related Articles

  • Arlington Cancer Center hosts international transplant forum. Giddens, C.D. // Business Press;8/09/96, Vol. 9 Issue 15, p6 

    Reports on the holding of Arlington Cancer Center's Eighth International Symposium on Autologous Marrow and Blood Transplantation on August 18-21, 1996 at the Marriott Hotel in Arington, Texas. Medical accomplishments produced by the symposium; Historical background on the symposium.

  • Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Cheuk, D. K. L.; Mok, A. S. P.; Lee, A. C. W.; Chiang, A. K. S.; Ha, S. Y.; Lau, Y. L.; Chan, G. C. F. // Bone Marrow Transplantation;Sep2008, Vol. 42 Issue 5, p319 

    In this cross-sectional study, we compared the quality of life (QOL) in transfusion-dependent thalassemic patients who survived matched sibling hematopoietic SCT (HSCT, n=24) with patients treated conventionally with transfusion and iron chelation (n=74). WHOQOL-BREF(HK) and PedsQL...

  • Qol in stem cell transplant patients.  // Cancer Nursing Practice;Dec2007, Vol. 6 Issue 10, p33 

    A quiz concerning the haemotopoietic stem cell transplant and quality of life of patients is presented.

  • Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases. Krüger, W; Rüssmann, B; Kröger, N; Salomon, C; Ekopf, N; Elsner, H-A; Kaulfers, P-M; Mack, D; Fuchs, N; Dürken, M; Kabisch, H; Erttmann, R; Zander, A R // Bone Marrow Transplantation;3/15/99, Vol. 23 Issue 6, p589 

    Infections are a major cause of morbidity and mortality in patients undergoing high-dose therapy and subsequent autologous or allogeneic haemopoietic stem cell transplantation, despite the change from topical to systemic anti-infection prophylaxis and the introduction of growth factors and new...

  • Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect. Alyea, E.; Weller, E.; Schlossman, R.; Canning, C.; Mauch, P.; Ng, A.; Fisher, D.; Gribben, J.; Freeman, A.; Parikh, B.; Richardson, P.; Soiffer, R.; Ritz, J.; Anderson, K. C. // Bone Marrow Transplantation;Dec2003, Vol. 32 Issue 12, p1145 

    Summary:A total of 228 patients with multiple myeloma (MM), 166 patients receiving autologous transplantation (124 PBSC and 38 BM) and 66 patients receiving T-cell-depleted allogeneic transplantation were analyzed to compare overall survival (OS), progression-free survival (PFS) and risk of...

  • Early and fatal immune haemolysis after so-called ‘minor’ ABO-incompatible peripheral blood stem cell allotransplantation. Oziel-Taieb, S; Faucher-Barbey, C; Chabannon, C; Ladaique, P; Saux, P; Gouin, F; Gastaut, J A; Maraninchi, D; Blaise, D // Bone Marrow Transplantation;6/1/97, Vol. 19 Issue 11, p1155 

    A 38-year-old man, blood group A+, was allotransplanted for multiple myeloma from his fully matched sister, blood group O+. Anti-A antibodies IgG and IgM titres of the donor were low. Allogeneic peripheral blood stem cells were harvested by leukapheresis after subcutaneous administration of...

  • BIOETHICAL CONCEPTS RELATED TO HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE RELIGIOUS AND SOCIO-CULTURAL CONTEXT. SASU, ALCIONA; ONEL, MIRCEA; GHIB-PARA, CRISTINA; VASILONI, FLORIN TRANDAFIR; NAAJI, ANTOANELA; COTORACI, CORALIA // Studia Universitatis Babes-Bolyai, Bioethica (2011);Dec2016, Vol. 61 Issue 1/2, p33 

    Translational medicine is a modern discipline which aims to create a bridge between experimental research, clinical research and implementation of all these scientific data into clinical practice. Translational medicine also entails legal and socio-cultural aspects that can decide the outcome of...

  • Patients’ psychosocial concerns following stem cell transplantation. Andrykowski, M A; Cordova, M J; Hann, D M; Jacobsen, P B; Fields, K K; Phillips, G // Bone Marrow Transplantation;11/15/99, Vol. 24 Issue 10, p1121 

    Information regarding the nature, frequency, correlates and temporal trajectory of concerns of stem cell transplantation (SCT) recipients is critical to the development of interventions to enhance quality of life (QOL) in these individuals. This study examined psychosocial concerns in 110 SCT...

  • Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients. Narvios, A. B.; de Lima, M.; Shah, H.; Lichtiger, B. // Bone Marrow Transplantation;Sep2005, Vol. 36 Issue 6, p499 

    Summary:Leukoreduction of blood components has been considered a safe alternative to screening donors for CMV. The objective of this study is to analyze the effectiveness of bedside leukoreduction in preventing CMV transmission. We retrospectively studied 72 transplant recipients and donors who...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics